Metformin as an anti-cancer agent against bladder cancer acts via PD-L1 downregulation in an orthotopic mouse model. Yeh CC, Tsai PC, Song YD, Low YS, et al. BMC Cancer 2025;25:1534.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yeh CC, Tsai PC, Song YD, Low YS, et al. Metformin as an anti-cancer agent against bladder cancer acts via PD-L1 downregulation in an orthotopic mouse model. BMC Cancer 2025;25:1534.
PMID: 41063036